Canada markets close in 3 hours 37 minutes

Oncolytics Biotech Inc. (ONC.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
1.2900-0.0100 (-0.77%)
As of 12:15PM EDT. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 99.91M
Enterprise Value 76.18M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)5.46
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.38
52-Week Change 3-54.06%
S&P500 52-Week Change 327.99%
52 Week High 33.1000
52 Week Low 31.2000
50-Day Moving Average 31.3604
200-Day Moving Average 31.4907

Share Statistics

Avg Vol (3 month) 332.79k
Avg Vol (10 day) 346.74k
Shares Outstanding 576.86M
Implied Shares Outstanding 678.06M
Float 873.76M
% Held by Insiders 13.82%
% Held by Institutions 11.76%
Shares Short (Aug 30, 2024) 4330.56k
Short Ratio (Aug 30, 2024) 48.67
Short % of Float (Aug 30, 2024) 40.46%
Short % of Shares Outstanding (Aug 30, 2024) 40.43%
Shares Short (prior month Jul 31, 2024) 4317.2k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 25, 2018
Ex-Dividend Date 4N/A
Last Split Factor 2105:1000
Last Split Date 3May 25, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-71.33%
Return on Equity (ttm)-138.22%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -36.45M
Net Income Avi to Common (ttm)-28.02M
Diluted EPS (ttm)-0.3800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)24.85M
Total Cash Per Share (mrq)0.32
Total Debt (mrq)1.12M
Total Debt/Equity (mrq)6.09%
Current Ratio (mrq)4.99
Book Value Per Share (mrq)0.24

Cash Flow Statement

Operating Cash Flow (ttm)-26.44M
Levered Free Cash Flow (ttm)-15.77M